| Entity | 3q27 rearrangements /NHL (non Hodgkin lymphomas) |
| Disease | B cell non-Hodgkin Lymphoma (B-NHL) carry the greatest number of translocations involving the BCL6 gene locus. Translocations are most commonly detected within 15-40% of Diffuse Large B-Cell Lymphomas (DLBCL), 6-15% of Follicular Lymphomas (FL), and 50% of nodular lymphocyte predominant Hodgkin Lymphomas. |
| Prognosis | Generally considered to be a better prognosis if there is increased expression of BCL6. The mechanism by which its expression is increased does not seem to matter (ie. different translocation partners increasing its expression results in the same prognosis). |
| Cytogenetics | 3q27 rearrangements/aberrations are diverse and include: translocations, micro-deletions, point mutations and hypermutation. Approximately 50% of 3q27 translocations involves Ig genes at 14q32 (IgH), 2p12 (IgK) and 22q12 (IgL) (e.g. t(3;14)(q27;q32). Less than half (~40%) include a variety of other chromosomal regions (1q21, 2q21, 4p11, 5q31, 6p21, 7p12, 8q24, 9p13, 11q13, 11q23, 12q11, 13q14-21, 14q11, 15q21; 16p11...). In addition, there are frequent bi-allelic alterations (translocation and deletion or mutation on the non-translocated allele). |
| Hybrid/Mutated Gene | Hybrid gene and transcripts are formed following promoter substitution between BCL6 and its different partners. Chimeric transcripts are generally detected containing the 5' part of the gene partner fused to the normal BCL6 exon 2 splice acceptor site. In some cases reciprocal chimeric transcripts driven by the 5' regulatory region of BCL6 fused to the partner gene coding region, have been characterised. t(2;3)(p12;q27) the gene in 2p12 is IGK t(3;3)(q25;q27) the gene in 3q25 is MBNL1 t(3;3)(q27;q27) the gene in 3q27 is ST6GAL1 t(3;3)(q27;q27) the gene in 3q27 is EIF4A2 t(3;3)(q27;q29) the gene in 3q29 is TFRC t(3;4)(q27;p13) the gene in 4p13 is RHOH t(3;6)(q27;p22) the gene in 6p22 is HIST1H4I t(3;6)(q27;p21) the gene in 6p21 is PIM1 t(3;6)(q27;p21) the gene in 6p21 is SFRS3 t(3;6)(q27;p21) the gene in 6p21 isHistone H4 t(3;6)(q27;p12) the gene in 6p12 is HSP90AB1 t(3;6)(q27;q15) the gene in 6q15 is SNHG5 t(3;7)(q27;p12) the gene in 7p12 is IKZF1 t(3;8)(q27;q24.1) the gene in 8q24.1 is MYC t(3;9)(q27;p11) the gene in 9p11 is GRHPR t(3;11)(q27;q23) the gene in 11q23 is POU2AF1 t(3;12)(q27;p13) the gene in 12p13 is GAPDH t(3;12)(q27;q12) the gene in 12q12 is LRMP t(3;12)(q27;q23) the gene in 12q23 is NACA t(3;13)(q27;q14) the gene in 13q14 is LCP1 t(3;14)(q27;q32) the gene in 14q32 is IGH t(3;14)(q27;q32) the gene in 14q32 is HSP90AA1 t(3;16)(q27;p13) the gene in 16p13 is CIITA t(3;16)(q27;p11) the gene in 16p11 is IL21R t(3;19)(q27;q13) the gene in 19q13 is NAPA t(3;22)(q27;q11) the gene in 22q11 is IGL |
| Abnormal Protein | No fusion protein. |
| | |
| LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas. |
| Kerckaert JP, Deweindt C, Tilly H, Quief S, Lecocq G, Bastard C |
| Nature genetics. 1993 ; 5 (1) : 66-70. |
| PMID 8220427 |
| |
| Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. |
| Ye BH, Lista F, Lo Coco F, Knowles DM, Offit K, Chaganti RS, Dalla-Favera R |
| Science (New York, N.Y.). 1993 ; 262 (5134) : 747-750. |
| PMID 8235596 |
| |
| Gene involved in the 3q27 translocation associated with B-cell lymphoma, BCL5, encodes a Krˆºppel-like zinc-finger protein. |
| Miki T, Kawamata N, Hirosawa S, Aoki N |
| Blood. 1994 ; 83 (1) : 26-32. |
| PMID 8274740 |
| |
| High BCL6 expression predicts better prognosis, independent of BCL6 translocation status, translocation partner, or BCL6-deregulating mutations, in gastric lymphoma. |
| Chen YW, Hu XT, Liang AC, Au WY, So CC, Wong ML, Shen L, Tao Q, Chu KM, Kwong YL, Liang RH, Srivastava G |
| Blood. 2006 ; 108 (7) : 2373-2383. |
| PMID 16772602 |
| |
| Intrachromosomal rearrangement of chromosome 3q27: an under recognized mechanism of BCL6 translocation in B-cell non-Hodgkin lymphoma. |
| Keller CE, Nandula S, Vakiani E, Alobeid B, Murty VV, Bhagat G |
| Human pathology. 2006 ; 37 (8) : 1093-1099. |
| PMID 16867873 |
| |
| Prognostic impact of chromosomal alteration of 3q27 on nodal B-cell lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 329 consecutive patients. |
| Niitsu N, Okamoto M, Nakamura N, Nakamine H, Aoki S, Hirano M, Miura I |
| Leukemia research. 2007 ; 31 (9) : 1191-1197. |
| PMID 17197022 |
| |
| Pathogenetic and clinical implications of non-immunoglobulin ; BCL6 translocations in B-cell non-Hodgkin's lymphoma. |
| Ohno H |
| Journal of clinical and experimental hematopathology : JCEH. 2006 ; 46 (2) : 43-53. |
| PMID 17142954 |
| |
| A novel t(2;3)(p11;q27) in a case of follicular lymphoma. |
| Tapinassi C, Micucci C, Lahortiga I, Malazzi O, Gasparini P, Gorosquieta A, Odero MD, Belloni E |
| Cancer genetics and cytogenetics. 2007 ; 172 (1) : 70-73. |
| PMID 17175383 |
| |
| A novel t(3;8)(q27;q24.1) simultaneously involving both the BCL6 and MYC genes in a diffuse large B-cell lymphoma. |
| Wang HY, Bossler AD, Schaffer A, Tomczak E, DiPatri D, Frank DM, Nowell PC, Bagg A |
| Cancer genetics and cytogenetics. 2007 ; 172 (1) : 45-53. |
| PMID 17175379 |
| |